Addus HomeCare (NASDAQ:ADUS) EVP David Tucker Sells 704 Shares

Addus HomeCare Corporation (NASDAQ:ADUS) EVP David Tucker sold 704 shares of Addus HomeCare stock in a transaction that occurred on Tuesday, February 24th. The shares were sold at an average price of $107.35, for a total transaction of $75,574.40. Following the transaction, the executive vice president directly owned 10,802 shares of the company’s stock, valued at approximately $1,159,594.70. This trade represents a 6.12% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Addus HomeCare Stock Performance

Shares of NASDAQ ADUS opened at $103.29 on Friday. The company has a market capitalization of $1.91 billion, a PE ratio of 19.83, a price-to-earnings-growth ratio of 1.49 and a beta of 0.91. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.66 and a current ratio of 1.80. The company’s fifty day moving average price is $109.41 and its 200 day moving average price is $113.01. Addus HomeCare Corporation has a 1 year low of $88.96 and a 1 year high of $124.43.

More Addus HomeCare News

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Stephens retained an “Overweight” rating on ADUS and set a $135 price target (trimmed from $140), keeping a constructive analyst opinion that supports medium-term upside. Read More.
• Positive Sentiment: Large institutional investors increased positions in recent quarters (Capital Research, Vanguard, Wasatch, State Street and others), signaling continued institutional confidence and buying power underneath the stock. Read More.
• Neutral Sentiment: Short-interest reporting is inconsistent across feeds (some entries show 0 shares, others show a material rise), creating data noise — investors should confirm with official FINRA/exchange data before sizing positions. Read More.
• Negative Sentiment: Insiders sold multiple tranches of stock on Feb. 24–25: CEO R. Dirk Allison sold several thousand shares (~7,300 across filings) and numerous EVPs also liquidated positions — concentrated insider selling often weighs on sentiment and can pressure the share price. Read More.
• Negative Sentiment: Reported short interest increased materially in February to roughly 1.15M shares (~6.5% of float, ~4.6 days to cover in mid-February) — a larger short book can amplify downside on negative headlines and increase volatility. Read More.
• Negative Sentiment: Media picked up a “pessimistic forecast” narrative tied to Stephens’ shorter-term expectations after the PT cut, which can reinforce selling pressure despite the retained Overweight rating. Read More.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on ADUS. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Addus HomeCare in a report on Wednesday, January 21st. Royal Bank Of Canada restated an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a research report on Wednesday. Barclays decreased their target price on Addus HomeCare from $117.00 to $112.00 and set an “underweight” rating on the stock in a research report on Tuesday. KeyCorp reissued an “overweight” rating on shares of Addus HomeCare in a report on Wednesday. Finally, Stephens reduced their price objective on shares of Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a research report on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Addus HomeCare has a consensus rating of “Moderate Buy” and an average price target of $134.33.

Institutional Investors Weigh In On Addus HomeCare

Large investors have recently modified their holdings of the business. Capital Research Global Investors raised its position in shares of Addus HomeCare by 22.3% in the fourth quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock valued at $157,837,000 after buying an additional 268,192 shares during the last quarter. Tributary Capital Management LLC grew its stake in Addus HomeCare by 114.1% during the 3rd quarter. Tributary Capital Management LLC now owns 398,122 shares of the company’s stock valued at $46,974,000 after acquiring an additional 212,192 shares in the last quarter. Freestone Grove Partners LP raised its holdings in Addus HomeCare by 5,035.2% in the 4th quarter. Freestone Grove Partners LP now owns 137,932 shares of the company’s stock valued at $14,813,000 after acquiring an additional 135,246 shares during the last quarter. 8 Knots Management LLC acquired a new stake in Addus HomeCare in the 3rd quarter valued at about $6,075,000. Finally, TimesSquare Capital Management LLC lifted its stake in Addus HomeCare by 13.9% in the 2nd quarter. TimesSquare Capital Management LLC now owns 394,047 shares of the company’s stock worth $45,390,000 after purchasing an additional 48,207 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.